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There was an omission of the first paragraph in the **Methods** section that was supported by one extra reference, hence the numbers in the reference list and the superscripted numbers, n, in the text, following reference 14, should now read n+1.

The paragraph is the following:

Design of the study {#sec1}
===================

This study was planned to evaluate the effect of reimbursement status on smoking cessation interventions, retrospectively, by using a study population, that applied at the free smoking-cessation medication distribution period, comprising groups that obtained the smoking cessation medications out of their own pocket. The free smoking-cessation medications distributed group's treatment adherence and quit success status were previously studied and published^14^. For this current study that group was used as a control group for evaluating a new research question. Ethical approval was obtained from the local ethics committee (number:78646441-050.01.04-date:19.04.2018), and permission for the study was also obtained from the General Secretary of the hospital.

The additional reference is:

14\. Karadoğan D, Önal O, Say Şahin D, Kanbay Y, Alp S, Şahin U. Treatment adherence and short-term outcomes of smoking cessation outpatient clinic patients. Tob Induc Dis. 2018;16(August). doi:10.18332/tid/94212
